Accrued Expenses

9 Months Ended

Sep. 30, 2021

Accrued Expenses

Accrued Expenses

Note 4. Accrued Expenses

The following is a summary of the Company’s accrued expenses:

	September 30,		December 31,
	2021		2020
Clinical trial expenses	$	2,699,793	$	2,510,111
Other		16,952		128,197
Total	$	2,716,745	$	2,638,308